Robert Lustig, MD "Fatty Liver, Sugar, Metabolic Syndrome, & Ozempic"
Navigating Early Clinical Drug Development Challenges
New Psychoactive Substances (NPS)
Biological Carbon Capture (Day or Night)
NAFLD — The Big Picture
Bioanalytical Method Validation of a Small Molecule in a Surrogate Matrix by LC-MS/MS
Robert Lustig, MD "Hateful-Grateful 8" a conversation with Ron Najafi
Hydroxy Radical Protein Footprinting (HRPF) and its relevance in Drug Development
Oncology Drug Modalities: A New Era in Oncology Drug Development
Psychedelics and Related Plasticity - Promoting Neurotherapeutics
Universal Immunity: Why people don’t generate broad spectrum responses to mutating viruses
Glycan Analysis Overview
Learn about Intact Mass and Subunit Analyses of a Therapeutic Antibody by Hi Res Orbitrap Mass Spec
Elucidating and Translating The Role of Glycans in Health and Diseases
The Subcellular Processes That Belie All Chronic Disease
cGMP NMR Capabilities
LC-MS Peptide Mapping
Medicinal and Synthetic Chemistry Services Overview
EFSA FEEDAP Guidance Presentation
Poloxamer detection used in applications of gene therapy and delivery
Ranitidine stability study
Nuclear Magnetic Resonance (NMR) Spectroscopy Overview
Liquid Chromatography/Mass Spectroscopy (LC-MS) Overview
Minimum Inhibitory Concentration (MIC) Assay Overview
Biofilm Profiling Services – Minimal Biofilm Eradicating Concentration (MBEC)
Testing Antimicrobial Activity and Cytotoxicity of Wound Care and Skin Cleanser
NMR Services Analysis
Testing Antimicrobial & Preservative Effectiveness